Remove topics phrma
article thumbnail

AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines?

The IPKat

This is the first in-person Congress since London hosted in 2019, so it was only apt that the first panel session was on the topic of IP and Covid-19. Ernest Kawka (Deputy VP, PhRMA) recapped the timeline of the Covid-19 pandemic, pointing to 11 January 2020 when Chinese scientists shared the sequence of Covid-19.